Prescription drug · ANDA
Hydroxyzine Pamoate NDC 71335-0998
Hydroxyzine pamoate 25 mg/1 · Capsule · Oral · Bryant Ranch Prepack
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 71335-0998-1 | 71335099801 | 20 CAPSULE in 1 BOTTLE (71335-0998-1)Marketed from Aug 31, 2020 | |
| 71335-0998-2 | 71335099802 | 30 CAPSULE in 1 BOTTLE (71335-0998-2)Marketed from Nov 12, 2018 | |
| 71335-0998-3 | 71335099803 | 100 CAPSULE in 1 BOTTLE (71335-0998-3)Marketed from Dec 28, 2021 | |
| 71335-0998-4 | 71335099804 | 10 CAPSULE in 1 BOTTLE (71335-0998-4)Marketed from Dec 28, 2021 | |
| 71335-0998-5 | 71335099805 | 15 CAPSULE in 1 BOTTLE (71335-0998-5)Marketed from Nov 27, 2018 | |
| 71335-0998-6 | 71335099806 | 60 CAPSULE in 1 BOTTLE (71335-0998-6)Marketed from Sep 30, 2021 | |
| 71335-0998-7 | 71335099807 | 90 CAPSULE in 1 BOTTLE (71335-0998-7)Marketed from Sep 16, 2021 | |
| 71335-0998-8 | 71335099808 | 120 CAPSULE in 1 BOTTLE (71335-0998-8)Marketed from Dec 28, 2021 | |
| 71335-0998-9 | 71335099809 | 42 CAPSULE in 1 BOTTLE (71335-0998-9)Marketed from Dec 28, 2021 |
How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Hydroxyzine Pamoate
- Generic name (nonproprietary)
- hydroxyzine pamoate
- Active ingredients
- Hydroxyzine pamoate — 25 mg/1
- Dosage form
- Capsule
- Route
- Oral
- Labeler
- Bryant Ranch Prepack
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 040156
- Marketing start
- Listing expires
- Other FDA classes
- Histamine Receptor Antagonists (Mechanism)
- Identifiers
- Product ID 71335-0998_029b06a0-5341-5a77-e063-6394a90a7ea2SPL ID 029b06a0-5341-5a77-e063-6394a90a7ea2SPL set ID f24c19d4-fd3e-4ed3-aeb7-7bc5e0dd0244RxCUI 995253UNII M20215MUFR
- Pharmacologic class
- Antihistamine
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N471335099801followed by a unit qualifier and the quantityPackage 71335-0998-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS For symptomatic relief of anxiety and tension associated with psychoneurosis and as an adjunct in organic disease states in which anxiety is manifested. Useful in the management of pruritus due to allergic conditions such as chronic urticaria and atopic and contact dermatoses, and in histamine-mediated pruritus. As a sedative when used as premedication and following general anesthesia, Hydroxyzine may potentiate meperidine (Demerol ® ) and barbiturates , so their use in pre-anesthetic adjunctive therapy should be modified on an individual basis. Atropine and other belladonna alkaloids are not affected by the drug. Hydroxyzine is not known to interfere with the action of digitalis…
Excerpt only. Read the full label for complete information.
Other NDCs under ANDA 040156
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Hydroxyzine Pamoate | Hydroxyzine pamoate 50 mg/1 | CapsuleOral | AvPAK | 50268-399 |
| Hydroxyzine Pamoate | Hydroxyzine pamoate 25 mg/1 | CapsuleOral | Amneal Pharmaceuticals of New York LLC | 0115-1803 |
| Hydroxyzine Pamoate | Hydroxyzine pamoate 50 mg/1 | CapsuleOral | Amneal Pharmaceuticals of New York LLC | 0115-1804 |
| Hydroxyzine Pamoate | Hydroxyzine pamoate 25 mg/1 | CapsuleOral | AvPAK | 50268-398 |
| Hydroxyzine Pamoate | Hydroxyzine pamoate 25 mg/1 | CapsuleOral | A-S Medication Solutions | 50090-4579 |
| Hydroxyzine Pamoate | Hydroxyzine pamoate 25 mg/1 | CapsuleOral | Proficient Rx LP | 71205-087 |
| Hydroxyzine Pamoate | Hydroxyzine pamoate 25 mg/1 | CapsuleOral | Proficient Rx LP | 71205-123 |
| Hydroxyzine Pamoate | Hydroxyzine pamoate 50 mg/1 | CapsuleOral | Bryant Ranch Prepack | 71335-1923 |
| Hydroxyzine Pamoate | Hydroxyzine pamoate 25 mg/1 | CapsuleOral | NCS HealthCare of KY, LLC dba Vangard Labs | 0615-8419 |
| Hydroxyzine Pamoate | Hydroxyzine pamoate 25 mg/1 | CapsuleOral | Aphena Pharma Solutions - Tennessee, LLC | 71610-217 |
| Hydroxyzine Pamoate | Hydroxyzine pamoate 50 mg/1 | CapsuleOral | NCS HealthCare of KY, LLC dba Vangard Labs | 0615-8420 |
| Hydroxyzine Pamoate | Hydroxyzine pamoate 25 mg/1 | CapsuleOral | NuCare Pharmaceuticals,Inc. | 68071-4915 |
| Hydroxyzine Pamoate | Hydroxyzine pamoate 50 mg/1 | CapsuleOral | DirectRx | 72189-315 |